The company says the full results of its study of the pill confirm promising early findings of the drug's protection against hospitalization and death.
Pfizer said Tuesday that its experimental COVID-19 pill appears to be effective against the Omicron variant of the coronavirus.onfirmed the pill’s promising early results
against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. The company said separate laboratory testing showed that the drug retained its potency against the Omicron variant, as many experts had predicted. Pfizer tested the antiviral drug against a man-made version of a key protein that the Omicron variant uses to reproduce itself.are expected to perform well against Omicron because they don’t target the coronavirus’ spike protein, which contains most of the new variant’s mutations.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer: Final data on pills to treat Covid-19 holds strong against hospitalization and deathPfizer's updated results for its experimental treatment for Covid-19 showed it cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms, the company announced in a news release Tuesday.
Read more »
Pfizer Says Its Covid-19 Pill Likely Works Against OmicronPfizer’s Covid-19 pill, which is up for FDA authorization, worked against Omicron in lab tests, the company said. A final analysis of a key study also confirmed the drug was 89% effective in high-risk adults.
Read more »
Pfizer confirms COVID pill's results, potency versus omicronPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. Separate laboratory testing shows the drug retains its potency against the omicron variant, the company announced, as many experts had predicted. Pfizer tested the antiviral drug against a man-made version of a key protein that omicron uses to reproduce itself.
Read more »
South Africa study shows two Pfizer shots may halt 70% of omicron hospitalizations: reportTwo shots of the COVID vaccine produced by Pfizer undefined and BioNTech undefined may offer 70% protection against hospitalizations due to the omicron...
Read more »
Pfizer vaccine protecting against hospitalisation during Omicron wave - studyTwo doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major real-world study on the potential impact of Omicron showed on Tuesday, as the country battles a spike in infections linked to the new variant.
Read more »
Pfizer Booster Shots Are Effective Against Omicron Variant, Israeli Study SaysPeople who had received a third shot of the Pfizer-BioNTech Covid-19 vaccine showed a level of neutralization against the Omicron variant about 100 times higher than those who had received two shots, a new Israeli study found
Read more »